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Letters to the EditorSAM.According to our data, however,
there were no differences in the rate of
semirigid ring usage or the average
size of the artificial ring between cases
with SAM and those without.4 The
present study lacks several detailed
data such as annular diameter or de-
gree of annular reduction. Therefore,
this issue lies beyond the scope of the
present study and may require further
investigation.
Their second comment refers to the
relationship between the thickness of
the interventricular septum (IVS) and
the development of SAM. A bulging
septum has been reported as a risk fac-
tor for SAM. Its mechanism has not
been well defined, but a bulging
septum may reduce the distance be-
tween mitral valve coaptation and
the left ventricular outflow tract, and
may increase the blood flow velocity
in the left ventricular outflow tract.
Said and colleagues5 reported 6 cases
in which a bulging septum was
considered the cause of SAM. Ac-
cording to the multivariate analysis
in the present study, the thickness of
the IVS is the independent risk factor
for SAM. However, we could not
demonstrate any cause and effect cor-
relation between the thickness of the
IVS and the risk of SAM, as seen in
the ejection fraction or end-systolic
diameter. We speculate that other fac-
tors such as the morphology of the
interventricular septum or the diam-
eter of the left ventricular outflow tract
may influence the development of
SAM. Therefore, this issue also re-
quires further investigation.
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To the Editor:
RayChu-JengChiu,MD, Professor
and past Director of the Division of
Cardiothoracic Surgery at McGill
University, passed away on January
4, 2014. Born in Tokyo, Japan, Dr
Chiu received an MD degree from
the National Taiwan University in
Taipei, Taiwan, followed by intern-
ship at Baltimore City Hospital. He
then undertook residency training in
Cardiovascular and Thoracic Surgery
under Clarence Dennis at Downstate
Medical Center in New York. After
obtaining a PhD in Experimental Sur-
gery at McGill University, Dr Chiu
joined the faculty at that University
in 1972, rising to the rank of full
tenured Professor in 1981. Hewas Di-
vision Chief from 1992 to 2000 and
spent his entire academic career at
McGill University. As a caring doc-
tor, Dr Chiu touched the lives of
many patients who benefited from
many of his innovative techniques
and procedures, such as the spiral
vena cava graft, dynamic cardiomyo-
plasty, retrograde coronary sinus cardi-
oplegia, and stem cell therapy for heart
failure. His contributions in the stem
cell field included studies on adult
stem cells derived from bone marrow,
placenta, and fat. His first report on
stem cell was in 1992 on cellular cardi-
omyoplasty, followed by his book inCardiovascular Surgery c May 20141997. His publications and original
contributions to the literature are
extensive, and hewas a visiting profes-
sor in most major universities world-
wide. Perhaps the recognition and
stature of Dr Chiu can be exemplified
by his participation in the Nominating
Committee for the Nobel Prize in
Physiology and Medicine in 1982.
Ray touched the lives of all those
who came in contact with him. He
was an inspiration and role model for
his students, residents, and peers.
Ray always had a kind voice for those
who searched advice from him. He
encouraged and helped his trainees to
do basic science and clinical research
and to write manuscripts, and made
them co-authors in his important con-
tributions. Being with Ray discussing
research ideas and projects was
inspiring and informative, always
leading to innovative and productive
projects. His honesty and dedication
were exemplary. His legacy will be
the way in which he touched and en-
riched the lives of so many who were
fortunate to have met him and the in-
fluence he had for those of his trainees
who pursued academic and leadership
careers. Hewill be sadlymissed as one
of the giants in cardiac surgery. He
leaves behind his wife Jane, daughter
Wendy, son Daniel, daughter-in-law
Lisa, and granddaughter Anya.
Tomas A. Salerno, MD
University of Miami Miller School of
Medicine
Miami, Fla
Jackson Memorial Hospital
Miami, Fla
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j.jtcvs.2014.01.033NOT CONVINCED THAT RIGHT
INTERNALTHORACIC ARTERY
IS SUPERIOR TO RADIAL
ARTERY
To the Editor:
We read with great interest the
study of Navia and colleagues1
Letters to the Editorcomparing the long-term outcomes
of patients undergoing all arterial
coronary artery bypass grafting
(CABG) according to whether the
second arterial graft was the right
internal thoracic artery (RITA) or
the radial artery (RA). We concur
with the opinion of Navia and
colleagues1 that there is a need to
raise awareness of the importance of
multiple arterial grafting in contem-
porary CABG surgery. This has
been a topic of primary interest for
our group during the past decade,2,3
with RA as our second arterial
graft of choice in conjunction with
the left internal thoracic artery.
Although we agree with the need for
wider adoption of multiple arterial
grafting in CABG surgery, we have
significant concerns regarding
the methodology of the analysis
of Navia and colleagues1 and
believe that the data, as presented,
can not support their conclusion that
the RITA is a superior conduit to
the RA.
Our specific issues are as follows.
First, although the overall study
group was composed of 1447 patients
receiving bilateral internal thoracic
artery (BITA) grafts and 253 patients
receiving RA grafts, the many signi-
ficant baseline differences between
the BITA and RA groups meant that
a very limited propensity-matched
comparison included only 149
matched RA and BITA pairs. This
small number severely limits the po-
wer of this analysis and consequently
any possible conclusions that can
be drawn about the impact of
the differential grafting strategy on
long-term outcomes.
Second, even given the very
limited number of patients in the final
matched comparison, we are not
certain that they were adequately
matched. To be able to attribute any
survival differences to the differential
grafting strategy in these dramati-
cally different study groups would
require a robust statistical adjust-
ment. Unfortunately we are notThe Journalconvinced that this was accom-
plished. The specific elements used
for propensity matching are not
explicitly stated. The article’s Table
31 specifies only 17 elements that
were used in deriving the propensity
score. If these were the only elements
used in the propensity matching, such
a modest number of elements raises
the possibility that the significant
baseline differences among the
groups may not have been adequately
adjusted by this technique. Notably
absent from the elements included
in this process were the completeness
of revascularization and the rate of
transfusion, both of which have
been shown to affect long-term
survival.3,4 We have used propensity
matching extensively in our
analyses of the impact of the RA
use on long-term outcomes and have
progressively refined these tech-
niques, relying on ever increasing
numbers of patient characteristics,
operative factors, and emerging peri-
operative events that are increasingly
recognized as important determi-
nants of long-term survival. In a
recent analysis,3 we relied on a pro-
pensity matching process composed
of 50 elements. We respectfully
submit that the validity of the
conclusions of Navia and colleagues1
would be significantly strengthened
by a more robust propensity match-
ing process.
Third, Navia and colleagues1 re-
ported a remarkably high in-hospital
mortality of 5.9% in the unadjusted
RA cohort and a 1.3% mortality in
the BITA cohort. After propensity
matching, the mortality was increased
to 4.03% in the BITA cohort and was
3.36% in the RA cohort. These rates
seem higher than anticipated in this
relatively healthy CABG group.
Importantly, these mortalities are
significantly higher than the recently
reported Society of Thoracic Sur-
geons mortality of 1.88%.5
Fourth, and most importantly, we
disagree with the conclusion that the
‘‘study provides evidence for theof Thoracic and Cardiovascular Surgersuperiority of the RITA compared to
the RA as a second arterial graft.’’
Furthermore, we find no support in
the data provided in the article to
support the claim in the Discussion
section that ‘‘the RA is not an equal
alternative conduit to the RITA
relative to . survival.’’ Specifically,
in the propensity-matched study
groups, the long-term survival, argu-
ably the most important long-term
outcome, was equivalent (P ¼ .65).
Navia and colleagues1 also chose
the relatively arbitrary end point of
postoperative readmission and rein-
tervention–free survival as the other
metric for judging the superiority of
the grafting strategy. Although this
clearly is an important outcome, we
believe that a more detailed assess-
ment of the components of this
benchmark, such as recurrent angina,
myocardial infarction, and details of
the reintervention required, would
be very helpful. Given the fact that
the propensity matched groups were
not adjusted for the completeness
of revascularization (RITA vs RA
distal anastomoses number 3.0 vs
2.7; P<.001), it is conceivable that
the increased reintervention rate
may have been more significantly
related to this phenomenon, rather
than a reflection of the quality of the
specific conduit used at the index
operation.
Although we believe that the
data presented do not in any way
answer the question in the title of
the study, we still wholeheartedly
applaud and support the dedication
to and use of multiple arterial
grafting in contemporary CABG
surgery as a means of enhancing
value for the patient and society
in an era of increasing resource
constraint.
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j.jtcvs.2014.01.036SHOULD SUTURELESS AORTIC
VALVE REPLACEMENT BE
PREFERRED ONLY FOR
DECREASING AORTIC
CROSSCLAMP TIME?
To the Editor:
We have read the article by Minh
and colleagues1 with great interest.
We appreciate the authors’ innova-
tive approach applied to concomitant
aortic and mitral valve diseases. The
efforts for defining new treatment
modalities have great importance
and are indispensable for scientific
development. However, the new
approach should scientifically correct
the shortcomings of the previously
performed procedure. With this
concern, we would like to discuss
the procedure performed by the
authors.1726 The Journal of Thoracic andThe only difference between suture-
less aortic valve replacement (AVR)
and surgical AVR is the decreased
aortic crossclamping time. The poten-
tial advantages of the procedure are
based on this fact. However, surgical
steps, including sternotomy, cardiopul-
monary bypass, aortic crossclamping,
cardioplegic arrest of the heart, and
aortotomy, are all the same when
comparing both procedures. Therefore,
the desired effect may not be demon-
strated in the long-term results, and
the superiority of sutureless AVR
over conventional AVR in octogenar-
ians may not be provided by only
decreasing the aortic crossclamp time,
because a large gap cannot be created
between the 2 methods when consid-
ering aortic crossclamp time. In addi-
tion, cardiac damage is related to how
the heart is protected rather than how
long the clamp is in place.2
The prosthesis is specifically de-
signed.Briefly, it consists of 2 cylindri-
cal ring segments on the proximal
(‘‘outflow’’ ring) and distal (‘‘inflow’’
ring) sides.3 Outflow and inflow rings
have been seated above and below the
aortic annulus, respectively. Although
the sutureless anchoring system re-
duces crossclamping time, it produces
an outward force affecting the aortic
annulus during balloon dilatation of
the prosthesis. The force used for dila-
tation was reported as 3 and 4 atm by
Flameng and colleagues4 and Hoang
Minh and colleagues,1 respectively,
that is, the pressures were equal to
2280 and 3040 mm Hg, respectively.
The effects of the force on the annulus
were not temporary bymeans of the ac-
quired constant shape of the prosthesis.
This may be the reason for permanent
pacemaker implantation1 and severe
bleeding secondary to rupture of the
aortic annulus.5 Except in the article
by D’Onofrio and colleagues,5 the re-
gions of life-threatening bleeding
were not explained in the articles.1,3,4
Determining whether the procedure is
safe or not is important for the readers.
After a successful implantation,
interaction between the outwardCardiovascular Surgery c May 2014force of the prosthesis and the oppo-
site resistance forces of the aortic
annulus tissue provides tight stabili-
zation. Loosening in the resistance
forces of the aortic annulus tissue
may cause paravalvular leak over
time because the aortic annulus is
not a stationary structure; it is always
in motion. Although HoangMinh and
colleagues1 did not observe paravalv-
ular leak, Folliguet and colleagues3
reported 9 patients (4%) with para-
valvular leak (7 patients in the early
follow-up period and 2 patients in
the late follow-up period).
Objective evaluation of the differ-
ent aspects of the procedure may
shed light on new methods to be
applied in the future. This approach
may be appreciated by the next
generation.
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